Literature DB >> 11802205

The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies.

Sofia Thelin-Järnum1, Melker Göransson, Alondra Schweizer Burguete, Anita Olofsson, Pierre Aman.   

Abstract

CHOP in 12q13, also called GADD153 or DDIT3, encodes a transcription factor of the C/EBP type. As a result of t(12;16) translocations, CHOP is rearranged and fused to TLS in 16p11 in about 90% of myxoid liposarcomas/round cell liposarcomas (MLS/RCLS). The TLS-CHOP protein consists of the N-terminal half of TLS juxtaposed to the N-terminal of the entire CHOP. It is capable of forming dimers with the natural dimer partners of CHOP. Here we report that recombinant TLS-CHOP-green fluorescence protein localizes to nuclear structures, similar to, but distinct from, PML nuclear bodies. The TLS-CHOP-green fluorescent protein nuclear structures are resistant to high salt concentration and nuclease treatment. Transfection of TLS-CHOP to normal fibroblasts causes a rapid down regulation and relocation of PML nuclear bodies. An abnormal extra nuclear localization of PML bodies was also found in TLS-CHOP carrying cell lines established from myxoid liposarcomas. Transfection of TLS-CHOP induced a rapid disappearance of PCNA. TLS-CHOP may disturb the nuclear machinery by binding and sequestering important factors from their natural sites. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802205     DOI: 10.1002/ijc.1632

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.

Authors:  Jeremy J Ryan; Macy L Sprunger; Kayla Holthaus; James Shorter; Meredith E Jackrel
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 2.  Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies.

Authors:  Richoo B Davis; Mahdi Muhammad Moosa; Priya R Banerjee
Journal:  Trends Cell Biol       Date:  2022-04-25       Impact factor: 21.167

3.  The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.

Authors:  Katarina Engström; Helena Willén; Christina Kåbjörn-Gustafsson; Carola Andersson; Marita Olsson; Melker Göransson; Sofia Järnum; Anita Olofsson; Elisabeth Warnhammar; Pierre Aman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

4.  Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153.

Authors:  Alexandra Jauhiainen; Christer Thomsen; Linda Strömbom; Pernilla Grundevik; Carola Andersson; Anna Danielsson; Mattias K Andersson; Olle Nerman; Linda Rörkvist; Anders Ståhlberg; Pierre Åman
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

5.  FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.

Authors:  Malin Lindén; Christoffer Vannas; Tobias Österlund; Lisa Andersson; Ayman Osman; Mandy Escobar; Henrik Fagman; Anders Ståhlberg; Pierre Åman
Journal:  Mol Oncol       Date:  2022-03-19       Impact factor: 7.449

6.  FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

Authors:  Malin Lindén; Christer Thomsen; Pernilla Grundevik; Emma Jonasson; Daniel Andersson; Rikard Runnberg; Soheila Dolatabadi; Christoffer Vannas; Manuel Luna Santamarίa; Henrik Fagman; Anders Ståhlberg; Pierre Åman
Journal:  EMBO Rep       Date:  2019-04-08       Impact factor: 8.807

7.  DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.

Authors:  Christoffer Bento; Mattias K Andersson; Pierre Aman
Journal:  BMC Cell Biol       Date:  2009-12-17       Impact factor: 4.241

8.  The oncogenic transcription factor FUS-CHOP can undergo nuclear liquid-liquid phase separation.

Authors:  Izzy Owen; Debra Yee; Hala Wyne; Theodora Myrto Perdikari; Victoria Johnson; Jeremy Smyth; Robert Kortum; Nicolas L Fawzi; Frank Shewmaker
Journal:  J Cell Sci       Date:  2021-09-03       Impact factor: 5.235

9.  The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.

Authors:  Mattias K Andersson; Anders Ståhlberg; Yvonne Arvidsson; Anita Olofsson; Henrik Semb; Göran Stenman; Ola Nilsson; Pierre Aman
Journal:  BMC Cell Biol       Date:  2008-07-11       Impact factor: 4.241

10.  Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses.

Authors:  David Svec; Soheila Dolatabadi; Christer Thomsen; Nicole Cordes; Mark Shannon; Paul Fitzpatrick; Göran Landberg; Pierre Åman; Anders Ståhlberg
Journal:  Lab Invest       Date:  2018-03-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.